My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

McKesson Corp (NY:MCK)

934.75 +18.75 (+2.05%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about McKesson Corp

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

20 21 Next >

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today ↗

April 03, 2024

Via Benzinga

Top Stock Reports For Apple, Nvidia & Eli Lilly ↗

April 01, 2024

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., NVIDIA Corporation, and Eli Lilly and Company.

Via Talk Markets

Peering Into McKesson's Recent Short Interest ↗

March 28, 2024

Via Benzinga

Rite Aid Forges Path To Financial Recovery With Major Settlement: Report ↗

March 27, 2024

Rite Aid (OTC: RADCQ) settles with lenders and DOJ, marking a crucial step toward bankruptcy resolution by April, Reuters reports. Attorney Aparna Yenamandra highlights broad stakeholder agreement,...

Via Benzinga

Topics Bankruptcy

$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today ↗

March 18, 2024

Via Benzinga

Which Stocks Will Dominate The Future Of Tech? UBS Shares Its Top Picks In AI, Healthtech, Greentech, And Fintech ↗

March 18, 2024

In a recent report, global wealth manager UBS has identified the sectors that are likely to drive the next wave of technological innovation and the stocks that stand to benefit.

Via Benzinga

Topics Artificial Intelligence

How Is The Market Feeling About McKesson? ↗

February 27, 2024

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today ↗

February 26, 2024

Via Benzinga

US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation ↗

February 14, 2024

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.

Via Benzinga

3 Attractive Medical Stocks To Buy After Earnings ↗

February 08, 2024

Quite a few top-rated stocks have highlighted this week’s earnings lineup with now appearing to be an ideal time to buy. Following their favorable quarterly results, here are 3 intriguing healthcare...

Via Talk Markets

Medical Supplies-Focused McKesson Shares Fall On Q3 Earnings Performance, Analyst Says Street 'Wanted More' ↗

February 08, 2024

McKesson beats expectations with Q3 2024 sales of $80.9 billion, up 15%. U.S. Pharmaceutical Segment thrives, adjusted EPS at $7.74, exceeding consensus.

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today ↗

February 08, 2024

Via Benzinga

McKesson (MCK) Q3 2024 Earnings Call Transcript ↗

February 07, 2024

MCK earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗

February 07, 2024

McKesson Corporation (NYSE: MCK) is expected to release earnings results for its third quarter, after the closing bell on Feb. 7, 2024.

Via Benzinga

Earnings Scheduled For February 7, 2024 ↗

February 07, 2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.

Via Benzinga

Earnings Preview: McKesson ↗

February 06, 2024

Via Benzinga

Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today ↗

January 19, 2024

Via Benzinga

S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday? ↗

February 07, 2024

Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments...

Via Benzinga

Topics Stocks

Fear & Greed Index Remains In 'Greed' Zone Following Earnings Reports; Dow Jumps Over 100 Points ↗

February 07, 2024

The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed higher on Tuesday, as...

Via Benzinga

Topics Stocks

Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 3 ↗

February 03, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Jan. 29 through Feb. 2.

Via Talk Markets

Peering Into McKesson's Recent Short Interest ↗

January 15, 2024

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today ↗

January 05, 2024

Via Benzinga

3 Hidden Healthcare Stocks Poised for a Breakout This Year ↗

January 30, 2024

As the market preferences start to switch toward stable and defensive names like healthcare, these stocks could help your portfolio.

Via InvestorPlace

Check Out What Whales Are Doing With MCK ↗

January 03, 2024

Via Benzinga

Exceeding Expectations: McKesson Achieves Strong Performance and Rewards Investors ↗

January 02, 2024

On January 02, 2024, McKesson (NYSE:MCK) will distribute a dividend payout of $0.62 per share, equating to an annualized dividend yield of 0.55%. Shareholders who owned the stock before the ex-dividend...

Via Benzinga

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population ↗

December 27, 2023

Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.

Via InvestorPlace

Topics Economy

How Is The Market Feeling About McKesson? ↗

December 25, 2023

Via Benzinga

Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug ↗

December 21, 2023

The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy...

Via Benzinga

Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years ↗

December 18, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About McKesson ↗

December 11, 2023

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.